Barclays
NITE

Barclays’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Barclays’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-42,673
Closed -$1.08M – 7542
2019
Q1 		$1.08M Buy
+42,673
New +$754K ﹤0.01% 3319

Barclays's NITE Position: Q2 2019 in Review

Barclays sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 42,673 shares — an estimated $1.08M sold.

Barclays first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $1.08M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • Barclays reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Barclays sold 42,673 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $1.08M.
  • Barclays first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
  • Barclays's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.08M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.